GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » Gross-Profit-to-Asset %

Indivior (LSE:INDV) Gross-Profit-to-Asset % : 55.76% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Indivior's annualized Gross Profit for the quarter that ended in Mar. 2024 was £749.2 Mil. Indivior's average Total Assets over the quarter that ended in Mar. 2024 was £1,343.6 Mil. Therefore, Indivior's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 55.76%.


Indivior Gross-Profit-to-Asset % Historical Data

The historical data trend for Indivior's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Gross-Profit-to-Asset % Chart

Indivior Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.65 34.11 39.68 43.05 47.83

Indivior Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.67 50.83 50.72 50.31 55.76

Competitive Comparison of Indivior's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Indivior's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indivior's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indivior's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Indivior's Gross-Profit-to-Asset % falls into.



Indivior Gross-Profit-to-Asset % Calculation

Indivior's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=716.53/( (1452.349+1543.66)/ 2 )
=716.53/1498.0045
=47.83 %

Indivior's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=749.224/( (1543.66+1143.511)/ 2 )
=749.224/1343.5855
=55.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Indivior Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Indivior's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Indivior (LSE:INDV) Business Description

Traded in Other Exchanges
Address
234 Bath Road, Slough, Berkshire, GBR, SL1 4EE
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.